Alterity Therapeutics Ltd (ASX:ATH)
A$ 0.005 0 (0%) Market Cap: 26.19 Mil Enterprise Value: 10.63 Mil PE Ratio: 0 PB Ratio: 0.56 GF Score: 0/100

Q2 2021 Alterity Therapeutics Ltd Earnings Call Transcript

Feb 25, 2021 / 10:00PM GMT
Release Date Price: A$0.039 (+2.63%)
Operator

Good morning, and welcome to the Alterity Therapeutics H1 Financial Results and Business update. (Operator Instructions)

Today's call is being recorded. And I'd like to introduce you to our host, Dr. David Stamler, Alterity Therapeutics Chief Executive Officer. He is joined by Mr. Geoffrey Kempler, Founder and Chairman; and Ms. Kathryn Andrews, the company's Chief Financial Officer.

Over to you, Dr. Stamler.

David A. Stamler
Alterity Therapeutics Limited - CEO, Chief Medical Officer & Senior VP of Clinical Development

Well, thank you, Greg. Good morning to our investors in Australia, and good afternoon to our investors here in the United States. Thank you for joining our call to discuss the first half year financial results and, more importantly, as a development stage company, our progress during the 6 months through December 2020 and during the first 2 months of this year.

Before turning to those topics, I'd like to first provide a little background on myself as I was appointed to the role of Chief Executive Officer in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot